These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8357353)
1. Targeting of experimentally induced atherosclerotic lesions by liposome-delivered Zn(II)-phthalocyanine. Visonà A; Jori G Atherosclerosis; 1993 May; 100(2):213-22. PubMed ID: 8357353 [TBL] [Abstract][Full Text] [Related]
2. Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits. Eldar M; Yerushalmi Y; Kessler E; Scheinowitz M; Goldbourt U; Ben Hur E; Rosenthal I; Battler A Atherosclerosis; 1990 Oct; 84(2-3):135-9. PubMed ID: 2282094 [TBL] [Abstract][Full Text] [Related]
3. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207 [TBL] [Abstract][Full Text] [Related]
4. Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. Ginevra F; Biffanti S; Pagnan A; Biolo R; Reddi E; Jori G Cancer Lett; 1990 Jan; 49(1):59-65. PubMed ID: 2302697 [TBL] [Abstract][Full Text] [Related]
5. Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Love WG; Duk S; Biolo R; Jori G; Taylor PW Photochem Photobiol; 1996 May; 63(5):656-61. PubMed ID: 8628757 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice. Reddi E; Lo Castro G; Biolo R; Jori G Br J Cancer; 1987 Nov; 56(5):597-600. PubMed ID: 3426922 [TBL] [Abstract][Full Text] [Related]
7. Spectroscopic studies on Zn(II)-phthalocyanine in homogeneous and microheterogeneous systems. Valduga G; Reddi E; Jori G J Inorg Biochem; 1987 Jan; 29(1):59-65. PubMed ID: 3559547 [TBL] [Abstract][Full Text] [Related]
8. A comparison of fluorescence methods used in the pharmacokinetic studies of Zn(II)phthalocyanine in mice. Biolo R; Jori G; Kennedy JC; Nadeau P; Pottier R; Reddi E; Weagle G Photochem Photobiol; 1991 Jan; 53(1):113-8. PubMed ID: 2027900 [TBL] [Abstract][Full Text] [Related]
9. On the source of the oscillations observed during in vivo zinc phthalocyanine fluorescence pharmacokinetic measurements in mice. Gudgin Dickson EF; Holmes H; Jori G; Kennedy JC; Nadeau P; Pottier RH; Rossi F; Russell DA; Weagle GE Photochem Photobiol; 1995 May; 61(5):506-9. PubMed ID: 7770513 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size, and composition. Isele U; Schieweck K; Kessler R; van Hoogevest P; Capraro HG J Pharm Sci; 1995 Feb; 84(2):166-73. PubMed ID: 7738795 [TBL] [Abstract][Full Text] [Related]
11. In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. van Leengoed HL; Cuomo V; Versteeg AA; van der Veen N; Jori G; Star WM Br J Cancer; 1994 May; 69(5):840-5. PubMed ID: 8180012 [TBL] [Abstract][Full Text] [Related]
12. Photofrin II uptake by atheroma in atherosclerotic rabbits. Fluorescence and high performance liquid chromatographic analysis on post-mortem aorta. Vever-Bizet C; L'Epine Y; Delettre E; Dellinger M; Peronneau P; Gaux JC; Brault D Photochem Photobiol; 1989 Jun; 49(6):731-7. PubMed ID: 2528156 [TBL] [Abstract][Full Text] [Related]
13. The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins. Polo L; Reddi E; Garbo GM; Morgan AR; Jori G Cancer Lett; 1992 Oct; 66(3):217-23. PubMed ID: 1451102 [TBL] [Abstract][Full Text] [Related]
14. Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours. Polo L; Segalla A; Jori G; Bocchiotti G; Verna G; Franceschini R; Mosca R; De Filippi PG Cancer Lett; 1996 Dec; 109(1-2):57-61. PubMed ID: 9020903 [TBL] [Abstract][Full Text] [Related]
15. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines. Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo. Yslas EI; Prucca C; Romanini S; Durantini EN; Bertuzzi M; Rivarola V Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):62-70. PubMed ID: 19447373 [TBL] [Abstract][Full Text] [Related]
17. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy. Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568 [TBL] [Abstract][Full Text] [Related]
18. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. Bachor R; Flotte TJ; Scholz M; Dretler S; Hasan T J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696 [TBL] [Abstract][Full Text] [Related]
19. Nuclear imaging potential and in vitro photodynamic activity of symmetrical and asymmetrical zinc phthalocyanines. Yurt Lambrecht F; Ocakoglu K; Er O; Ince M; Gunduz C; Kayabası C J Labelled Comp Radiopharm; 2016 May; 59(5):221-7. PubMed ID: 27059543 [TBL] [Abstract][Full Text] [Related]
20. The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins. Polo L; Bianco G; Reddi E; Jori G Int J Biochem Cell Biol; 1995 Dec; 27(12):1249-55. PubMed ID: 8581821 [No Abstract] [Full Text] [Related] [Next] [New Search]